bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
2.880
+0.220 (8.27%)
At close: Oct 14, 2025, 4:00 PM EDT
2.775
-0.105 (-3.65%)
After-hours: Oct 14, 2025, 7:59 PM EDT
bioAffinity Technologies Employees
bioAffinity Technologies had 57 employees as of December 31, 2024. The number of employees decreased by 18 or -24.00% compared to the previous year.
Employees
57
Change (1Y)
-18
Growth (1Y)
-24.00%
Revenue / Employee
$134,755
Profits / Employee
-$205,069
Market Cap
12.93M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 57 | -18 | -24.00% |
| Dec 31, 2023 | 75 | 61 | 435.71% |
| Dec 31, 2022 | 14 | 3 | 27.27% |
| Dec 31, 2021 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BIAF News
- 5 days ago - WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules - PRNewsWire
- 5 days ago - bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules - Business Wire
- 6 days ago - WallachBeth Capital Announces bioAffinity Technologies Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules - PRNewsWire
- 6 days ago - bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules - Business Wire
- 7 days ago - bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025 - Business Wire
- 14 days ago - WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8m - PRNewsWire
- 14 days ago - bioAffinity Technologies Announces Closing of $4.8 Million Public Offering - Business Wire
- 15 days ago - WallachBeth Capital Announces Pricing of bioAffinity Technologies Public Offering for $4.8m - PRNewsWire